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Abstract
Background: M.tb icd-1 and M.tb icd-2, have been identified in the Mycobacterium tuberculosis
genome as probable isocitrate dehydrogenase (ICD) genes. Earlier we demonstrated that the two
isoforms can elicit B cell response in TB patients and significantly differentiate TB infected
population from healthy, BCG-vaccinated controls. Even though immunoassays suggest that these
proteins are closely related in terms of antigenic determinants, we now show that M.tb icd-1 and
M.tb icd-2 code for functional energy cycle enzymes and document the differences in their
biochemical properties, oligomeric assembly and phylogenetic affiliation.
Results: Functionally, both M.tb ICD-1 and ICD-2 proteins are dimers. Zn+2 can act as a cofactor
for ICD-1 apart from Mg+2, but not for ICD-2. ICD-1 has higher affinity for metal substrate complex
(Km (isocitrate) with Mg++:10 µM ± 5) than ICD-2 (Km (isocitrate) with Mg++:20 µM ± 1). ICD-1
is active across a wider pH range than ICD-2, retaining 33–35% activity in an acidic pH upto 5.5.
Difference in thermal behaviour is also observed with ICD-2 being active across wider temperature
range (20°C to 40°C) than ICD-1 (optimum temperature 40°C). The isozymes are NADP+
dependent with distinct phylogenetic affiliations; unlike M.tb ICD-2 that groups with bacterial ICDs,
M.tb ICD-1 exhibits a closer lineage to eukaryotic NADP+ dependent ICDs.
Conclusion: The data provide experimental evidence to show that the two open reading frames,
Rv3339c (ICD-1) and Rv0066c (ICD-2), annotated as probable ICDs are functional TCA cycle
enzymes with identical enzymatic function but different physio-chemical and kinetic properties. The
differences in biochemical and kinetic properties suggest the possibility of differential expression of
the two ICDs during different stages of growth, despite having identical metabolic function.
Background
The central metabolic pathways in bacteria, especially in
E.coli, have been extensively studied to understand the
physiology of the organisms under altered carbon sources
[1]. One of the key regulatory enzymes in the universal tri-
carboxylic acid energy cycle is the isocitrate
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of oxidative decarboxylation of D-isocitrate to α-ketoglu-
tarate and CO2 in presence of a cofactor [2]. This rate-lim-
iting step is the first NADPH yielding reaction of the TCA
cycle [2]. Isocitrate dehydrogenase belongs to a family of
enzymes that exhibits diversity with regard to amino acid
composition, cofactor specificity, metal ion requirement
and oligomeric state. NADP-linked ICDs have been puri-
fied and studied from a variety of eukaryotes and prokary-
otes with detail investigations on their subunit
composition and kinetic properties [3-11]. ICD from dif-
ferent organisms has been phylogenetically affiliated to
three subfamilies [12]. Majority of the bacterial ICDs fall
into subfamily I that includes archaeal and bacterial
NADP dependent ICDs.
M. tb genome has two isoforms of isocitrate dehyrogen-
ase, Rv3339c (ICD-1) and Rv0066c (ICD-2), both anno-
tated as probable isocitrate dehydrogenase based on
homology with other enzymes of the ICD family [13]. The
two isoenzymes are share only ~14% identity at amino
acid level. Earlier, we have pointed to a very unusual prop-
erty of this TCA cycle enzyme demonstrating that the two
isoforms can elicit B cell response in TB patients and sig-
nificantly discriminate healthy, BCG-vaccinated controls
from different groups of TB-infected population when
compared to PPD and control antigen M.tb HSP 60 [14].
Although the two isoforms have primarily similar anti-
genic properties, little is known about their enzymatic
properties. We now document differences in their bio-
chemical properties, subunit composition and phyloge-
netic association. Our study provides experimental
evidence to show that the two ORFs are TCA cycle
enzymes with identical enzymatic function but different
physio-chemical and kinetic properties.
Results
Expression, purification and quantification of M.tb ICD-1 
and ICD-2
The over-expressed N-terminal His-tagged M.tb ICD-1 and
M.tb ICD-2 were purified on a Nickel affinity column to
95% and 90% homogeneity, respectively (Figure 1, inset).
The molecular sizes of the recombinant proteins M.tb
ICD-1 and M.tb ICD-2 were determined by SDS-PAGE
analyses and were found to be ~ 49 kDa and ~ 86 kDa
respectively. The purification was carried out under native
conditions for both the proteins from soluble fractions
with an yield of 3.25 mg for M.tb ICD-1 and 10.21 mg for
M.tb ICD-2 per 500 ml start culture [14].
The ORFs encoding hypothetical protein M. tb ICD-1 
(Rv3339c) and the probable ICD2 (Rv0066c) are 
functionally expressed as evident from serological 
evidences
The M. tb icd-1 and M. tb icd-2, both are annotated as the
probable isocitrate dehydrogenase based on the sequence
homology with ICD-family of enzymes. Serological evi-
dences reveal the presence of antibody titers against both
the purified proteins ICD-1 and ICD-2 in the infected sera
samples [14]. Figure 1 is a sample representation of ten
patients each for ICD-1 (sample 1–10) and ICD-2 (sam-
ple 11–20) with their respective healthy controls (Figure
1; 21–25, control reactions for ICD-1 and 26–30, control
reactions for ICD-2) suggesting that both the ORFs encod-
ing ICDs are expressed at the protein level as evident from
antibodies in TB infected patient sera.
Biochemical characterization reveals differences between 
ICD-1 and ICD-2 in terms of pH and heat stability
In order to determine the kinetic parameters, the stabiliz-
ing components in the reaction like pH, temperature, salt
M. tb Rv3339c (ICD-1) and Rv0066c (ICD-2) are expressed at the protein levelFigure 1
M. tb Rv3339c (ICD-1) and Rv0066c (ICD-2) are 
expressed at the protein level. Antibody response to M. 
tb ICD-1 and ICD-2 was determined by ELISA. Sample repre-
sentation of ten M. tb patient sera out of 125 showing high 
immunogenic response when compared with healthy con-
trols. Y axis represents absorbance values at 492λ and X axis 
represents random patient sera tested for M. tb ICD-1 and 
ICD-2 antigenic response. 1 – 10, antigen ICD-1; 11 – 20, 
antigen ICD-2; 21 – 25, Healthy controls for ICD-1; 26 – 3, 
Healthy controls for ICD-2. Inset: Affinity purification of M. 
tb ICD-1 and M. tb ICD-2. The different lanes are: lanes 1: M. 
tb ICD-1; lane M: protein molecular size markers (200 kDa, 
116 kDa, 97 kDa, 66 kDa, 45 kDa, 31 kDa and 21.5 kDa); 
lanes 2: M. tb ICD-2.Page 2 of 14
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cificity were tested for each enzyme for optimal activity.
Figure 2 shows relative percentage of activity retained by
the enzymes with respect to different pH. While the opti-
mum pH for both isoenzyme is 7.5, M. tb ICD-1could tol-
erate a wider pH range retaining ~30% activity in acidic
pH 5.5 to ~ 90% activity in alkaline pH 9.5 (Figure 2). In
contrast, M. tb ICD-2 could retain only 10.22% of activity
at a pH of 5.5, which gradually decreased to only 3.4% at
pH 4, and less than 40% at 9.5 (Figure 2). These results
clearly suggest that M. tb ICD-1 is active across a wider
range of pH than M. tb ICD-2.
Optimum temperature and thermostability of M. tb ICD-
1 and M.tb ICD-2 were studied by varying the temperature
of the reaction from 20°C to 70°C with incubation time
of 30 minutes for each reaction. The optimum tempera-
ture for the activity of M. tb ICD-1 is ~40°C (Figure 3)
while M. tb ICD-2 shows almost similar activity across
20°C to 40°C. Thermal stability of the two enzymes,
however, varied. M. tb ICD-1 retained ~40% activity till
60°C, where M. tb ICD-2 was only ~5% active at that tem-
perature (Figure 3). Thermal inactivation remained irre-
versible after incubation at 65°C for half an hour for M. tb
ICD-1. M. tb ICD-2 could be renatured upon slow cooling
till 55°C where partial activity was restored. Complete
denaturation of the protein was observed at about 60°C
(Figure 3). Similarity in thermal behaviour of the two
enzymes is apparent, however fine differences could be
registered.
The decrease in the activity at higher salt concentration 
indicates involvement of ionic interactions during catalysis 
of M. tb ICD-1 and ICD-2
We determined the effect of NaCl on the stability as well
as activity of the enzymes. The absence of NaCl in the
reaction buffer did not affect the activity of M. tb ICD-1
significantly but M. tb ICD-2 showed higher activity in
presence of upto 200 mM of NaCl as compared when no
NaCl was added in the reaction. Presence of salt in the
reaction buffer probably maintains the integrity of the
enzymes. Higher concentrations of salt (above 200 mM)
proved to be detrimental for the activities of both the
enzymes (Figure 4a and 4b). The purified recombinant
proteins, ICD-1 and ICD-2 degraded less at room temper-
ature when dialysed against atleast 100 mM NaCl. The
decrease in the activity at higher salt concentration indi-
cates involvement of ionic interactions during catalysis.
The reversibility of the inactivation of the enzyme activi-
ties after removal of excess salt has not been tested as the
enzymes had a tendency to precipitate upon long expo-
sure to room temperature or even 4°C during dialysis.
M. tb ICD-1 and M. tb ICD-2 are NADP-dependent and 
have differential metal cofactors requirement
The coenzyme specificity of M. tb ICD-1 and M. tb ICD-2
was confirmed by checking the activity with both NADP+
M. tb ICD-1 was active across a wider range of pH than M. tb ICD-2Figure 2
M. tb ICD-1 was active across a wider range of pH 
than M. tb ICD-2. Activity of M. tb ICD-1 and M. tb ICD-2 
was tested as a function of pH (4 to 10). The buffers used for 
the experiment were: 30 mM Na-acetate buffer (pH 4.0 to 
pH 5.5), 20 mM phosphate buffer (pH 5.7 to pH 7), 30 mM 
imidazole buffer (pH 6 to pH 7) and 20 mM Tris buffer (pH 
7.5 to pH 10).
ICD-1 and ICD-2 exhibit differential activity as a function of temperatureFigure 3
ICD-1 and ICD-2 exhibit differential activity as a 
function of temperature. The enzyme activity was 
assayed at different temperatures (20°C to 70°C).Page 3 of 14
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that M. tb ICDs are NADP+ – dependent members of the
isocitrate dehydrogenase family and shows no activity
whatsoever in presence of NAD+.
The two enzymes were tested for metal ion requirement
with respect to four divalent metal ions, namely, Mg++,
Zn++ and Mn++ and Ca++. It was apparent that M. tb ICD-1
accepts both Mg++and Zn++ as divalent metal ion cofactor
Activity of M. tb ICDs decrease at higher salt concentrationFigure 4
Activity of M. tb ICDs decrease at higher salt concentration. Activity of the enzymes ICD-1 (a) and ICD-2 (b) was 
measured by reduction of NADP at different concentrations of NaCl. The enzymes were active in presence of 200 mM NaCl 
above which the activity rapidly decreases.
The M. tb ICDs are NADP+ dependentFigure 5
The M. tb ICDs are NADP+ dependent. Coenzyme specificity of M. tb ICD-1(a) and M. tb ICD-2 (b) was assayed in pres-
ence of NADP+ and NAD+ as coenzymes. The activity curves clearly indicate that M. tb ICD-1 as well as M. tb ICD-2 are 
NADP+ dependent enzymes.Page 4 of 14
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(Figure 6a). This is unlike M. tb ICD-2, which accepts only
Mg++ as metal ion and shows no activity with either Zn++,
Ca++ or Mn++ (Figure 6b). The saturation kinetics indicates
a complete saturation at 10 mM of metal ion for both
Mg++ and Zn++ (data not shown).
Kinetic parameters and feedback inhibition of M. tb ICDs
The basic enzyme kinetics parameters Km, Vmax and Kcat
for DL-isocitrate and NADP+ were determined for both
ICD-1 and ICD-2 (Table 1). Km (isocitrate) in presence of
either Mg++ or Zn++ for M. tb ICD-1 was calculated to be 10
µM ± 5 and 22 µM ± 7, respectively. For M. tb ICD-2, the
value is 20 µM ± 1 in presence of Mg++ suggesting that M.
Comparative rate curves for the enzyme activities in presence of metal ionsFigure 6
Comparative rate curves for the enzyme activities in presence of metal ions. a) Rate curves of M. tb ICD-1 and b) 
Rate curves of M. tb ICD-2 in presence of Mg++, Zn++, Ca++ and Mn++ as cofactors. The details of the reactions are described in 
the method section.
Table 1: Kinetic parameters for M. tb ICD-1 and M. tb ICD-2 with respect to Mg++ and Zn++
Kinetic parameters With MgCl2 With ZnCl2
M. tb ICD-1
Km(isocitrate) 10 µM ± 5 22 µM ± 7
Vmax(isocitrate) 380 µM NADPH/min 190 µM NADPH/min
Kcat (isocitrate) 3.8 µM NADPH/min/pM enzyme 1.9 µM NADPH/min/pM enzyme
Km(NADP+) 125 µM ± 5 -
Vmax(NADP+) 400 µM NADPH/min -
Kcat (NADP+) 4 µM NADPH/min/pM enzyme -
M. tb ICD-2
Km(isocitrate) 20 µM ± 1 No activity
Vmax(isocitrate) 371.3 µM NADPH/min
Kcat (isocitrate) 37.13 µM NADPH/min/pM enzyme
Km(NADP+) 19.6 µM ± 6
Vmax(NADP+) 374 µM NADPH/min
Kcat (NADP+) 37.4 µM NADPH/min/pM enzyme
Ki(NADPH) 0.46 × 10-5 M.Page 5 of 14
(page number not for citation purposes)
BMC Biochemistry 2005, 6:20 http://www.biomedcentral.com/1471-2091/6/20tb ICD-1 has higher affinity for Mg-substrate complex
than
Zn-substrate and also more readily binds to metal-sub-
strate complex than M.tb ICD-2. The observation that
these enzymes showed no activity upon pre-incubation
with isocitrate and NADP+ in absence of metal ions sug-
gests that they are unable to utilize free isocitrate as a
substrate. Km (NADP) values in presence of Mg++ for M.tb
ICD-1 and M. tb ICD-2 are 125 µM ± 5 and 19.6 µM ± 6,
respectively. Competitive inhibition was observed with
NADPH versus NADP+for M. tb ICD-2 (Figure 7). The
mean inhibitor constant, Ki, was calculated to be 0.46 ×
10-5 M. Competitive inhibition of M.tb ICD-2 by NADPH
indicates the regulation of this enzyme by feedback
mechanism (Figure 7). Since M. tb ICD-1 showed very
poor affinity for NADP+ (125 µM ± 5), similar feedback
inhibition was not observed.
Oligomeric assemblies of M. tb ICDs
Size exclusion chromatography was performed to check
the oligomeric assembly of the recombinant M.tb ICD-1
and M.tb ICD-2. The chromatogram for M.tb ICD-1
showed two distinct peaks indicating presence of two
oligomeric species in the solution (Figure 8). The first
peak corresponds to a mass of ~200 kDa (tetrameric)
while the major peak showed migration of the molecule
as a mass of ~100 kDa (dimeric). The results show M.tb
ICD-1 to exist in either minor tetrameric or major dimeric
state. In order to evaluate the functional significance of
the two oligomeric states in catalysis of M.tb ICD-1, each
fraction was collected separately and checked for the activ-
ity. While the dimeric fraction showed complete activity,
the tetrameric fraction displayed a rather insignificant
activity (Figure 8, inset). A few dimeric species that might
have originated due to distintegration of the tetrameric
form may account for the insignificant activity of the col-
lected tetrameric fraction. The monomeric form was pre-
viously checked for the activity and was found to be
inactive (data not shown). Thus, the oligomeric func-
tional form of the M.tb ICD-1 is a dimer.
The gel filtration analysis were performed with high per-
formance column Superose™ 6 10/300 GL for higher res-
olution using an automated chromatographic
workstation (BioRad BioLogic Duoflow™) to confirm the
oligomeric state of M. tb ICD-2. The experiments were per-
formed with the concentrated protein (~400 µg) under
both low (100 mM NaCl) and high (1 M NaCl) salt
conditions. The chromatogram showed a peak
Lineweaver Burk plot for competitive inhibition of M. tb ICD-2Figur  7
Lineweaver Burk plot for competitive inhibition of M. tb ICD-2.Page 6 of 14
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condition, which was dissociated into a dimer (~180
KDa) at a high salt concentration of 1 M, but not into a
monomer (Figure 9, lower panel). The broadening of the
ICD-2 peak under low salt concentration at higher elution
volume points to the existence of lower oligomeric spe-
cies. Sharpness of the peak under 1 M salt corresponding
to a dimeric size provides strong evidence that the most
stable oligomeric state is a dimer.
These conclusions were further supported by UV (figure
10a) and chemical crosslinking data (figure 10b). It was
observed that UV crosslinking gave a distinct dimeric
species. However, chemical crosslinking with glutaralde-
hyde was more efficient and it showed bands correspond-
ing to both dimer and trimer forms of M. tb ICD2.
We also performed chemical crosslinking in presence and
absence of coenzyme (NADP) and substrate (Isocitrate). A
band corresponding to a trimer was consistently present
with the dimeric band (figure 10c). Since the gel filtration
data under low salt condition showed a tendency of form-
ing lower oligomeric states, we further explored if under
any salt condition a trimeric species that was observed in
crosslinking could be obtained. Therefore the gel filtration
assay was repeated under an intermediate (500 mM) salt
concentration. Figure 10d shows a peak representing a
mixture of trimeric and dimeric species under this buffer
condition. Therefore, we conclude that M. tb ICD-2 is not
a monomeric protein under any conditions tested in this
study. Eventhough it can exist in higher oligomerc forms,
dimer represented the most stable form that could not be
further dissociated into monomers in our buffer condi-
tion. The above result equivocally demonstrate that M. tb
ICD-2 is not a monomer and exists in higher oligomeric
state in contrary to what has been reported in the annota-
tion of H37Rv genome.
M. tb ICD-1 and M. tb ICD-2 have different phylogenetic 
affiliations
The ICD-1 and ICD-2 were aligned at the protein
sequence level, with the corresponding sequences from a
range of organism from both prokaryotes and eukaryotes,
after a BLAST search (data not shown, but available upon
request). Based on the sequence alignment using CLUS-
TAL, phylogenetic analyses were carried out. Neighbour
Joining rooted trees with Thermotoga maritima isocitrate
dehydrogenase as outgroup were constructed for both
ICD-1 and ICD-2. The confidence was assessed by
bootstrap analysis as described in Materials and Methods.
The results reveal a closer relationship of the functionally
conserved residues of M. tb ICD-1 with eukaryotic NADP+
dependent isocitrate dehydrogenases (Figure 11). The
closest prokaryotic neighbour of M. tb ICD-1 was Bifido-
bacterium longum. The NADP-dependent isocitrate dehy-
drogenases of the following prokaryotes were found to
cluster with M. tb ICD-1: Spingobium yanoikuyae, Caulo-
bacter crescentes, Agrobacterium tumefacians, Brucella sp.,
Sinnorhizobium meliloti etc (Figure 11). M. tb ICD-1
showed no similarity with any of the mycobacterial ICDs
in the protein database, including the second isoform of
Mycobacterium tuberculosis, M. tb ICD-2. The phylogenetic
tree of M. tb ICD-2 however, is a total contrast of M. tb
ICD-1, where it clusters with other NADP+ dependent
ICDs of gram-ve bacteria (Figure 12).
Discussion
Our results demonstrate for the first time experimentally
that the two M. tb ORFs Rv3339c and Rv0066c code for
M. tb ICD-1 is a homodimer as evident from gel filtration analysisFigure 8
M. tb ICD-1 is a homodimer as evident from gel fil-
tration analysis. The elution profiles of recombinant M. tb 
ICD-1 on a Superdex-200 HR 10/30 column showed two 
peaks corresponding to tetrameric (200 KDa) and dimeric 
(100 KDa) state of the protein. Inset: Comparative activity of 
the collected fractions.Page 7 of 14
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BMC Biochemistry 2005, 6:20 http://www.biomedcentral.com/1471-2091/6/20Originally annotated as a monomer, M. tb ICD-2 exists as a homodimerFigure 9
Originally annotated as a monomer, M. tb ICD-2 exists as a homodimer. The elution profiles of recombinant M.tb 
ICD-2 on high performance column SuperoseTM 6 10/300 column. The lower panel of the chromatogram shows a peak corre-
sponding to a tetramer (~320 KDa) under low salt condition, which was dissociated into a dimer (~180 KDa) at a high salt con-
centration of 1 M. The collected elution fractions run on 7% SDS-PAGE are shown under respective peaks. The upper panel 
represent chromatographic peaks corresponding to the protein markers; Thyroglobulin (669 KDa), Apoferritin (443 KDa), 
BSA (66 KDa) and Carbonic anhydrase (29 KDa). Inset: The calibration curve plotted as Ve/Vo versus log of molecular mass 
for calculating molecular weights of the oligomeric assembly.Page 8 of 14
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sion of D-isocitrate to α-ketoglutarate and CO2 in pres-
ence of NADP as cofactor and differ in their biochemical
properties. Interestingly, an altogether different
functionality of these two isoforms in immune recogni-
tion was evident from our earlier work [14]. We have bio-
chemically characterized the two isoforms of M. tb ICDs
and established the differences between them.
Isocitrate dehydrogenase is an important regulatory
enzyme of TCA cycle that has been intensively studied in
both prokaryotes and eukaryotes (3–11). It lies at the
branchpoint between glyoxylate shunt and citric acid
cycle in prokaryotes where the switchover from TCA cycle
to glyoxylate shunt depends upon the alteration in the
biochemical parameters of isocitrate dehydrogenase.
Isocitrate lyase of glyoxylate shunt pathway has much
lower affinity for the isocitrate and cannot compete with
isocitrate dehydrogenase for the substrate under normal
conditions. It has been reported that phosphorylation of
ICD controls the flux of isocitrate between the Krebs cycle
and the glyoxylate pathway [15,16]. In E.coli, where
glyoxylate bypass and citric acid cycle operate concur-
rently, the activity of a single, functional isocitrate
Crosslinking profiles of M. tb ICD2Figure 10
Crosslinking profiles of M. tb ICD2. A. UV crosslinking profile, B. Chemical crosslinking using glutaraldehyde, C. Glutaral-
dehyde crosslinking with substrate (Isocitrate) and coenzyme (NADP). UV crosslinking profile clearly shows a band corre-
sponding to a homodimeric species. Chemical crosslinking with glutaraldehyde in presence and absence of NADP and 
Isocitrate was more efficient and showed bands corresponding to both dimer and trimer forms of M.tb ICD 2. D. The gel filtra-
tion assay under an intermediate (500 mM) salt concentration revealed a peak representing a mixture of trimeric and dimeric 
species. The collected elution fractions were run on 7% SDS-PAGE. D (Inset): The calibration curve plotted as Ve/Vo versus 
log of molecular mass for calculating molecular weights of the oligomeric assembly.Page 9 of 14
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however, glyoxylate bypass is observed inside macro-
phages where C2 substrate is the main carbon source [19].
The occurrence of two isoforms of ICD in M. tb genome
with the possibility of each having characteristic biochem-
ical properties is interesting under such circumstances.
M. tb ICD-1 and ICD-2 follow a first order reaction and
exhibit typical saturation kinetics. Km (isocitrate) value
for M. tb ICD-1 clearly indicates a high affinity of this
enzyme for isocitric acid as compared to M. tb ICD-2. Km
(isocitrate) of some of the known NADP+ dependent ICD
has been presented in Table 2 for reference and compari-
son [3-11]. Several other probable substrates for M. tb
ICD-1 with close structural similarity were tested. Two
such substrates were aspartate and glutamate. Both the
compounds have close similarity with isocitric acid. How-
ever, the poor activity of the enzyme with these substrates
M. tb ICD 1 is closer to eukaryotic NADP+ ICDsFigure 11
M. tb ICD 1 is closer to eukaryotic NADP+ ICDs. A 50% consensus bootstrap neighbour joining tree of M. tb ICD-1 with 
Thermotoga maritima as outgroup. The numerical values represent the confidence assessed by bootstrap analysis. The tree 
depicts a closer lineage of M. tb ICD-1 with eukaryotic NADP dependent isocitrate dehydrogenases. The amino acid sequence 
alingnment of ICDs from these organisms showed more than 65% identity with all the major catalytically important residues 
conserved (refer text).Page 10 of 14
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a substrate (data not shown).
The fact that M. tb ICD-1 could tolerate a broad range of
both pH and temperature (Figure 2, 3) than M. tb ICD-2
indicates its robustness. The difference in the pH tolerance
helps to postulate the possibility of differential expression
of the two isoforms with ICD-1 being expressed during
stationary phase when the intracellular pH is expected to
vary over a wider range than log phase.
Km (NADP+) of M. tb ICD-1 showed poor affinity for
NADP+ as compared to M. tb ICD-2 and other known
NADP-dependent isocitrate dehydrogenases (Table 2).
The poor affinity of M. tb ICD-1 to NADP+ warranted an
investigation on whether dual co-enzyme specificity
occurs in M. tb ICD-1 as reported in some archaeal
bacteria [12]. We, therefore, compared the enzymatic
activity of both the enzymes in presence of NADP+ and
NAD+ (Figure 5a and 5b). It can be clearly seen that M. tb
ICD-1 as well as M. tb ICD-2 accepts NADP+ and not
NAD+ as a proton acceptor.
The homodimeric state of M. tb ICD-1 is the functionally
active species, even though residual activity was noticed in
tetrameric fraction which could be a reflection of the pres-
ence of a few dimeric species as a consequence of disinte-
gration of the tetrameric forms. The chromatogram peak
for M. tb ICD-2 corresponding to a tetramer (~320 KDa)
under low salt condition, which was dissociated into a
dimer (~180 KDa) at a high salt concentration of 1 M, but
not into a monomer (Figure 9) provided a strong evidence
that the most stable form of M. tb ICD-2 is a dimer. An
intermediary trimeric form was observed in chemical
crosslinking assays (Figure 10b and 10c), both in presence
and absence of coenzyme NADP and substrate isocitric
acid. The data were consistent with the gel filtration pro-
file under an intermediate (500 mM) salt concentration
M. tb ICD-2 is closer to prokaryotic NADP+ ICDsFigure 12
M. tb ICD-2 is closer to prokaryotic NADP+ ICDs. Rooted neighbour joining phylogenetic tree of M. tb ICD-2 with Ther-
motoga maritima as outgroup. The numerical values represent the confidence assessed by bootstrap analysis. ICD-2 clusters 
with NADP+ dependent ICDs of gram-ve bacteria. M. tb ICD-2 has closest homology with Mycobacterium leprae showing 85.4% 
similarity at protein level. Other close neighbours are human pathogens like Pseudomonas aeruginosa (65%), Vibrio cholerae 
(60%), Neisseria menengitidis (59%) etc.Page 11 of 14
(page number not for citation purposes)
BMC Biochemistry 2005, 6:20 http://www.biomedcentral.com/1471-2091/6/20(Figure 10d) where it showed a peak representing a
mixture of trimeric and dimeric species. We therefore
could conclude that M. tb ICD-2 is not a monomeric
protein. Our result indicates M. tb ICD-2 exists in different
higher oligomeric states which may follow the following
equilibria: [tetramer] ⇔ [trimer] ⇔ [dimer]. However, the
physiological relevance of the different oligomers could
not be concluded from our experiments.
Earlier attempt to trace the evolution of ICDs to under-
stand the adaptive role of isocitrate dehydrogenase in
intracellular persistence of this pathogen by Steen et al
[12] does not place M. tb ICD-2 phylogenetically. Proxim-
ity of the two M. tb ICDs with other isocitrate dehydroge-
nases was determined. Our results on phylogenetic
analysis of M. tb ICD-1 revealed a closer relationship with
eukaryotic NADP+ dependent ICDs (Figure 11) with more
than 65% identity with that of Glycine max, Sus scrofa, Bos
and Homo sapiens. M. tb ICD-1, indeed, is correctly placed
in subfamily II that includes eukaryotic NADP dependent
ICDs and a single bacterial ICD (Sphingomonas yanoikuyae)
[12]. With NADP+ dependent isocitrate dehydrogenase of
Sphingomonas yanoikuyae, M. tb ICD-1 has more than 65%
similarity at primary structure level. Phylogenetic analysis
of M. tb ICD-2 showed that the classical nomenclature
applies to ICD-2 and it can be placed in subfamily I, the
closest being M. leprae (Figure 12). The closest bacterial
relative of M. tb ICD-1 as inferred by our study is NADP
dependent isocitrate dehydrogenase of Bifidobacterium
longum (Figure 11). Bifidobacterium sp. are gram positive,
anaerobic, natural components of human intestinal
microbiota [20]. This might be argued as a case of hori-
zontal transfer or lateral transfer of gene amongst unre-
lated organisms across the boundaries of phylogenetic
domains. Horizontal transfer of genes is a common
occurrence in nature and accounts for almost 10–50% of
genes in bacteria [21,22].
Conclusion
Several ORFs have been characterized since deciphering of
M. tb genome [23-25]. Our data represent conclusive
proof that the two ORFs, Rv3339c and Rv0066c, are func-
tional TCA cycle enzyme and represent the first attempt to
characterize these important members of the TCA cycle of
Mycobacterium tuberculosis. Our studies conclusively reveal
that both ICD-1 and ICD-2 are NADP+ dependent
members of ICD family with the former having closer
homology with eukaryotic ICDs and latter with prokaryo-
tes. ICD-1 is a homodimer, while ICD-2 annotated as a
monomer, exists in higher oligomeric forms, the dimer
being the most stable. The two isoforms differ in their
affinity for coenzyme NADP as represented by their
Km(NADP) values (Table 1) and also with respect to pH
tolerance and thermostability.M. tb ICD-2 is a more effi-
cient enzyme as inferred by comparing Vmax(NADP)/
Km(NADP) ratios for the two enzymes but M. tb ICD-1 is
more robust in terms of pH tolerance and thermostability.
The possibilities of differential expression of these two
isoforms during different stages and conditions of growth
cannot be ruled out even though the two isoforms have
identical enzymatic function.
Methods
Cloning and purification of M. tb ICDs
The 1.230 kb (ICD-1) and 2.238 kb (ICD-2) long ORF
was amplified from H37Rv genomic DNA and overex-
pressed in the pRSET-A/E.coli BL-21 (DE3) expression
system as described earlier [14]. The overexpressed his-
tagged recombinant protein was purified by Ni2+-nitrilot-
riacetate affinity chromatography.
Table 2: Comparison of NADP+-dependent isocitrate dehydrogenases from different organisms.
Organism Km(isocitrate) Km(NADP+)
Blastocladiella emersonii 20 µM 10 µM
Chlorobium limicola 45 µM ± 13 27 µM ± 10
Bacillus substilis 5.9 µM ± 0.9 14.5 µM ± 2.2
Escherichia coli 4.9 µM ± 0.2 19.6 µM ± 3.6
Synechocystis sp PCc 6803 59 µM 12 µM
Pyrococcus furiosus - 4400 µM
Aeropyrum pernix - 30 µM
Thermotoga moritima - 55.2 µM
Aeropyrum fulgidus - 30 µM
Mycobacterium phlei (ATCC-354) 74 µM 53 µM
M. tb ICD-1 10 µM ± 5 125 µM ± 5
M. tb ICD-2 20 µM ± 1 19.6 µM ± 6
Beef liver NADP+-IDH 1.7 µM 7.3 µM
Rat liver (cytosolic) 9.7 µM ± 2.9 11.5 µM ± 0.2
Porcine heart NADP+ IDH - 5 µM ± 0.19Page 12 of 14
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ELISAs were performed with purified recombinant pro-
teins, as described earlier [14], to check the B cell immune
response in TB patient sera as evidence to the in vivo
expression of the proteins.
Dehydrogenase kinetics/biochemical assays
Dehydrogenase activity was measured spectrophotometri-
cally by monitoring the time dependent reduction of
NADP+ to NADPH at 25°C in Unicam UV/Vis
spectrometer at 340 nm, the absorbance maximum of
NADPH. The standard assay solution contained 20 mM
triethanolamine chloride buffer pH 7.5, 2 mM NADP+,
0.03 mM DL-isocitrate, 10 mM MgCl2/10 mM ZnCl2, 100
mM NaCl and 10 -100 pM of the enzyme in a final vol-
ume of 400 µL. Environmental parameters for the
enzymes were measured by altering the pH of the buffer
(range 4 – 10), temperature (20 – 65°C), concentration of
substrate (0.01 mM – 0.18 mM), cofactor (0.1 – 2 mM),
metal ion (Mg++, Zn++, Mn++; 1 – 12.5 mM) and salt
(100 mM – 500 mM) requirement (as indicated in the
respective figure legends. The pH dependence of the
enzyme was measured using the following buffers: 30 mM
Na-acetate buffer (pH 4.0 to pH 5.5), 20 mM phosphate
buffer (pH 5.7 to pH 7), 30 mM imidazole buffer (pH 6
to pH 7) and 20 mM Tris buffer (pH 7.5 to pH 10). The
cofactor specificity was checked with both NADP+ and
NAD+. The heat denaturation was studied in 20 mm tri-
ethanolamine chloride buffer pH 7.5 in presence of 1%
bovine serum albumin. Enzyme aliquotes were placed in
tubes and incubated for 30 minutes in a water bath set at
the required temperature (20°C – 65°C). After heating,
aliquotes were immediately placed on ice and then
assayed for remaining enzyme activity.
The kinetic analysis was carried out at 25°C and pH 7.5 in
presence of either Mg++ or Zn++. Km was determined by
altering the concentration of either the substrate or the
coenzyme. The substrate concentration gradient varied
from 0.01 mM to 0.75 mM, while NADP+ concentration
was taken from 0.1 mM to 2 mM. The values were plotted
as V vs S for calculating Km and Vmax for this first order
reaction. The results were counter checked by double
inverse Lineweaver-Burk plot. Competitive inhibition was
observed with reduced NADP (NADPH) versus NADP to
estimate inhibitor constant, Ki. Standard Km analysis was
performed followed by repeating the assay with NADPH.
Two concentrations of the inhibitor were tested, 0.002
mM and 0.005 mM. The uninhibited run provided the
value of Km for the reaction and the inhibited run
provided the apparent Km (Kmapp) for the reaction. Ki
for the competitive inhibition was calculated by the for-
mula (Km) (I)/Kmapp – Km.
Size exclusion chromatography
Size exclusion chromatography was performed at room
temperature using FPLC equipped with Superdex-200 HR
10/30 column (Amersham Pharmacia Biotech) and
SuperoseTM 6 10/300 GL (BioRad BioLogic Duo-flow™).
Calibration of the columns were performed using protein
molecular-mass standards for gel-filtration (Sigma, USA)
as described elsewhere [26]. The void volume (Vo) was
determined by running Blue Dextran on the column. The
calibration curve was plotted as Ve/Vo versus log of
molecular mass. A 2.4 mg/ml (for ICD-1) and 1.06 mg/ml
(for ICD-2) concentrations of recombinant proteins were
used for all gel filtration experiments. The columns were
equilibrated with three bed volumes of the elution buffer
prior to each run. Protein elution was monitored at A280.
UV and chemical crosslinking
UV crosslinking assays were performed to check the oligo-
meric assembly of M. tb ICD2. 5 µg of protein per
reaction, in TrisCl buffer pH 8, was taken and exposed to
UV in a UVP CL-1000 Ultraviolet crosslinker for 1 to 10
minutes at the rate of 1600 Joules/minute and fractioned
later on 10% SDS-PAGE along with similar amount of
untreated M. tb ICD2 as control. For chemical
crosslinking, the protein was equilibrated in 20 mM phos-
phate buffer pH7.8. 10 mM Glutaraldehyde was used for
all the chemical crosslinking reactions. The protein sam-
ples were incubated at 37°C, with or without glutaralde-
hyde. The reaction was stopped at different time points
(10' or 20') using SDS loading dye containing 400 mM
glycine and subsequently fractionated on 7% SDS-PAGE.
1 mM of either NADP or Isocitrate was used wherever
required.
Sequence alignment and phylogenetic analysis
The amino acid sequence of M.tb ICD-1 and M.tb ICD-2
were compared against the NCBI protein database [27].
The sequences with the BLAST score upto e-153 or 65%
identity were selected for construction of the phylogenetic
tree. The sequences were aligned using CLUSTAL pro-
gram. Manual alignment was done by Jalview [28]
wherever required. The sequence alignment is available
on request from the authors. Rooted phylogenetic tree
were constructed using the software MEGA3 [29] using
the amino acid sequence of Thermotoga maritima isocitrate
dehydrogenase as outgroup. The confidence was assessed
by bootstrap analysis (thousand replicates using default
parameters).
List of abbreviations
ICD, isocitrate dehydrogenas; M. tb, Mycobacterium tuber-
culosis; TCA, tricarboxylic acid; NADP, nicotinamide ade-
nine dinucleotide phosphate; BSA, Bovine Serum
Albumin; NAD, nicotinamide adenine dinucleotide;
NADPH, reduced nicotinamide adenine dinucleotidePage 13 of 14
(page number not for citation purposes)
BMC Biochemistry 2005, 6:20 http://www.biomedcentral.com/1471-2091/6/20Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
phosphate; bp, base pair(s); kb, kilobase pair(s); kDa, kilo
Daltons, pM, pico molar; µM, micro molar.
Authors' contributions
SB has contributed in conception and designing of all
experiments, biochemical assays and in-silico analysis,
interpretation of data and writing the draft manuscript.
AN carried out the biochemical assays and, participated in
the sequence alignment and phylogenetic analysis. RP did
the cloning and purification of proteins. VMK was
involved in overall designing of this study, critical analysis
of the data and also provided the biological material and
quality control. SEH have been involved in complete
supervision and guiding the work, providing the intellec-
tual inputs, revising the draft version and preparing the
final version of the manuscript.
Acknowledgements
This work was supported by research grants to SEH from the Council of 
Scientific and Industrial Research (CSIR) and Department of Biotechnology, 
Government of India. S B was supported by a Senior Research Fellowship 
from CSIR. We thank Dr. Ranjan Sen and Dr. Shekhar C Mande, Centre for 
DNA Fingerprinting and Diagnostics for helpful discussions. We wish to 
thank Sriramana, Laboratory of Molecular Genetics, Bibhusita, Jisha, Nancy 
and Irfan of Transcriptional Biology Laboratory, CDFD for their help and 
co-operation.
References
1. Holms H: Flux analysis: a basic tool of microbial physiology.
Adv Microb Physiol 2001, 45:271-340.
2. Stryer L: Biochemistry.  4th edition. W. H. Freeman and Co., USA;
1995. 
3. Kanao T, Kawamura M, Fukui T, Atomi H, Imanaka T: Characteri-
zation of isocitrate dehydrogenase from the green sulfur
bacterium Chlorobium limicola, A carbon dioxide-fixing
enzyme in the reductive tricarboxylic acid cycle.  Eur J Biochem
2002, 269:1926-1931.
4. Muro-Pastor MI, Florencio FJ: Purification and properties of
NADP-isocitrate dehydrogenase from the unicellular cyano-
bacterium Synechocystis sp.  Eur J Biochem 1992, 203:99-105.
5. Reeves HC, Daumy GO, Lin CC, Houston M: NADP+-specific iso-
citrate dehydrogenase of Escherichia coli. I. Purification and
characterization.  Biochim Biophys Acta 1972, 258:27-39.
6. Vasquez B, Reeves HC: NADP-specific isocitrate dehydroge-
nase from Escherichia coli. V. Multiple forms of the enzyme.
Biochim Biophys Acta 1981, 660:16-22.
7. Chen R, Yang H: A highly specific monomeric isocitrate dehy-
drogenase from Corynebacterium glutamicum.  Arch Biochem
Biophys 2000, 383:238-245.
8. Balamir A: NADP-linked isocitrate dehydrogenase from beef
liver: a new method of purification and the effect of metal
ion cofactor on its stability.  Biochem Med 1983, 29:194-206.
9. Jennings GT, Minard KI, McAlister-Henn L: Expression and muta-
genesis of mammalian cytosolic NADP+-specific isocitrate
dehydrogenase.  Biochemistry 1997, 36:13743-13747.
10. Soundar S, Danek BL, Colman RF: Identification by mutagenesis
of arginines in the substrate binding site of the porcine
NADP-dependent isocitrate dehydrogenase.  J Biol Chem 2000,
275:5606-5612.
11. Dhariwal KR, Venkitasubramanian TA: NADP-specific isocitrate
dehydrogenase of Mycobacterium phlei ATCC 354: purifica-
tion and characterization.  J Gen Microbiol 1987, 133:2457-2460.
12. Steen IH, Madern D, Karlstrom M, Lien T, Ladenstein R, Birkeland
NK: Comparison of isocitrate dehydrogenase from three
hyperthermophiles reveals differences in thermostability,
cofactor specificity, oligomeric state, and phylogenetic
affiliation.  J Biol Chem 2001, 276:43924-43931.
13. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al.:
Deciphering the biology of Mycobacterium tuberculosis from
the complete genome sequence.  Nature 1998, 393:537-544.
14. Banerjee S, Nandyala A, Podili R, Katoch VM, Murthy KJ, Hasnain SE:
Mycobacterium tuberculosis (Mtb) isocitrate dehydrogenases
show strong B cell response and distinguish vaccinated con-
trols from TB patients.  Proc Natl Acad Sci USA 2004,
101:12652-12657.
15. Kornberg HL: The role and control of the glyoxylate cycle in
Escherichia coli.  Biochem J 1966, 99:1-11.
16. Singh SK, Miller SP, Dean A, Banaszak LJ, LaPorte DC: Bacillus sub-
tilis Isocitrate Dehydrogenase. a substrate analogue for
Escherichia coli isocitrate dehydrogenase kinase/phos-
phatase.  J Biol Chem 2002, 277:7567-7573.
17. Holms WH: Control of flux through the citric acid cycle and
the glyoxylate bypass in Escherichia coli.  Biochem Soc Symp 1987,
54:17-31.
18. Holms H: Flux analysis and control of the central metabolic
pathways in Escherichia coli.  FEMS Microbiol Rev 1996, 19:85-116.
19. McKinney JD, Honer zu BK, Munoz-Elias EJ, Miczak A, Chen B, Chan
WT, Swenson D, et al.: Persistence of Mycobacterium tuberculo-
sis in macrophages and mice requires the glyoxylate shunt
enzyme isocitrate lyase.  Nature 2000, 406:735-738.
20. Xu J, Gordon JI: Honor thy symbionts.  Proc Natl Acad Sci USA 2003,
100:10452-10459.
21. Schnarrenberger C, Martin W: Evolution of the enzymes of the
citric acid cycle and the glyoxylate cycle of higher plants. A
case study of endosymbiotic gene transfer.  Eur J Biochem 2002,
269:868-883.
22. Lorencz MG, Wackernagel W: Bacterial gene transfer by natural
genetic transformation in the environment.  Microbial Reviews
1994, 58:563-602.
23. Choudhary RK, Mukhopadhyay S, Chakhaiyar P, Sharma N, Murthy
KJR, Katoch VM, Hasnain SE: PPE antigen Rv2430c of Mycobac-
terium tuberculosis induces a strong B-Cell response.  Infection
Immunity 2003, 71:6338-6343.
24. Chakhaiyar P, Nagalakshmi Y, Aruna B, Murthy KJR, Katoch VM,
Hasnain SE: Regions of high antigenicity within the hypotheti-
cal PPE major polymorphic tandem repeat open-reading
frame, Rv2608 show a differential humoral response and a
low T cell response in various categories of patients with
tuberculosis.  J Infect Dis 2004, 190:1237-1244.
25. Chakhaiyar P, Hasnain SE: Defining the mandate of tuberculosis
research in a postgenomic era.  Med Princ Pract 2004, 13:177-184.
26. Chauhan R, Mande SC: Characterization of the Mycobacterium
tuberculosis H37Rv alkyl hydroperoxidase AhpC points to
the importance of ionic interactions in oligomerization and
activity.  Biochem J 2001, 354:209-215.
27. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local
alignment search tool.  J Mol Biol 1990, 215:403-410.
28. Clamp M, Cuff J, Searle SM, Barton GJ: The Jalview Java alignment
editor.  Bioinformatics 2004, 20:426-437.
29. Kumar S, Tamura K, Nei M: Integrated software for Molecular
Evolutionary Genetics Analysis and sequence alignment.
Brief Bioinform 2004, 5:150-163.Page 14 of 14
(page number not for citation purposes)
